Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine

Vaccine

Volumn 16, Issue 1, 1998, Pages 16-23

  Xing, Dorothy K L ^a   Canthaboo, Catpagavalli ^a   Corbel, Michael J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Macrophage activity; Nitric oxide; Pertussis vaccine

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PERTUSSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERTUSSIS; PRIORITY JOURNAL; PROTECTION; SPLEEN CELL;

ANIMALS; BORDETELLA PERTUSSIS; CELLS, CULTURED; FEMALE; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; PERTUSSIS VACCINE; SPLEEN;

EID: 0031986341     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00157-6     Document Type: Article

References (47)

1. Friedman R.L. Pertussis: the disease and new diagnostic methods. Clin. Microbiol. Rev. 1:1988;365-376.
2. Manclark, C.R. and Cowell, J.L. Pertussis. In: Bacterial Vaccines (Ed. Germanier, R.). Academic Press, Orlando, FL, 1984, pp. 60-106.
3. Weiss A.A., Hewlett E.L. Virulence factors of Bordetella pertussis. Annu. Rev. Microbiol. 40:1986;661-686.
4. Thomas M.G., Redhead K., Lambert H.P. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J. Infect. Dis. 159:1989;211-218.
5. Thomas M.G., Ashworth L.A.E., Miller E., Lambert H.P. Serum IgG, IgA and IgM responses to pertussis toxin, filamentous haemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J. Infect. Dis. 160:1989;838-845.
6. Sato H., Sato Y. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous haemagglutinin with mouse protectivity in an intra cerebral or aerosol challenge system. Infect. Immun. 46:1984;415-421.
7. Sato H., Sato Y., Ohishi I. Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies. Infect. Immun. 59:1991;3832-3835.
8. Oda M., Cowell J.L., Burstyn D.G., Thaib S., Manclark C.R. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect. Immun. 47:1985;441-445.
9. Roberts M., Tite J.P., Fairweather N.F., Dougan G., Charles I.G. Recombinant P 69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection. Vaccine. 10:1992;43-48.
10. Griffiths, E. Efficacy of whole-cell pertussis vaccine. In: Pathogenesis and Immunity in Pertussis (Eds Wardlaw, A.C. and Parton, R.). John Wiley, Chichester, 1988, pp. 353-374.
11. Redhead K. Serum antibody responses to the outer membrane proteins of Bordetella pertussis. Infect. Immun. 44:1984;724-729.
12. Ashworth L.A.E., Robinson A., Irons L.I., Morgan C.P., Isaacs D. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Lancet. II:1983;878-881.
13. Tomoda T., Ogura H., Kurashige T. Immune responses to Bordetella pertussis infection and vaccination. J. Infect. Dis. 163:1991;559-563.
14. Petersen J.W. Cellular immunity in relation to pertussis vaccination and infection. Danish Med. Bull. 42:1995;121-140.
15. Alonso J.M., Ravisse P., Brezin C. Bordetella pertussis respiratory infection in C57BL/6 and Balb/c mice: pathophysiology and immune responses. FEMS Microbiol. Lett. 40:1987;273-277.
16. Pittman M., Furman B.L., Wardlaw A.C. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J. Infect. Dis. 142:1980;56-65.
17. Plotkin, S. and Cadoz, M. An interpretation of the acellular pertussis vaccine trials. In: Acellular Pertussis Vaccine Trails, Abstract. National Institutes of Health Pertussis Conference, Washington, June 1996.
18. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J. Infect. Dis. 161:1990;487-492.
19. Bass J.W., Zacher L.L. Do newborn infants have passive immunity to pertussis? Pediatr. Infect. Dis. J. 8:1989;352-353.
20. Adamson P.C., Wu T.C., Meade B.D., Rubin M., Manclark C.R., Pizzo P.A. Pertussis in a previously immunized child with human immunodeficiency virus infection. J. Pediatr. 115:1989;589-592.
21. Ng V.L., York M., Hadley W.K. Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome. J. Clin. Microbiol. 27:1989;337-338.
22. Bromberg K., Tannis G., Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:1991;4715-4719.
23. Petersen J.W., Andersen P., Ibsen P.H., Capiau C., Wachman C.H., Haslov K., Heron I. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine. 11:1993;463-472.
24. Fish F., Cowell J.L., Manclark V.C.R. Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect. Immun. 44:1984;1-6.
25. Mills, K.H.G., Barnard, A., Watkins, J. and Redhead, K. Specificity of the T-cell response to Bordetella pertussis in aerosol-infected mice. In: Proc. Sixth Int. Symp. on Pertussis (Ed. Manclark, C.R.). US Public Health Service, Bethesda, MD, 1990, pp. 166-174.
26. Mills K.H.G., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:1993;399-410.
27. Cheers C., Gray D.F. Macrophage behaviour during the complaisant phase of murine pertussis. Immunology. 17:1969;875-887.
28. Ewanowich C.A., Melton A.R., Weiss A.A., Sherburne R.K., Peppler M.S. Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect. Immun. 57:1989;2698-2704.
29. Lee, C.K., Roberts, A.L., Finn, T.M. and Mekalanos, J.J. Invasion of HaLa 229, Chinese hamster ovary, and U937 cells by Bordetella pertussis. In: Proc. Sixth Int. Symp. on Pertussis (Ed. Manclark, C.R.). US Public Health Service, Bethesda, MD, 1990, pp. 115-125.
30. Saukkonen K., Cabellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1991;1143-1149.
31. Friedman R.L., Nordensson K., Wilson L., Akporiaye E.T., Yocum D.E. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:1992;4578-4585.
32. Babior B.M. The respiratory burst of phagocytes. J. Clin. Invest. 73:1984;599-601.
33. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412.
34. Albina J.E., Abate J.A., Henry W.L. Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of INF-gamma in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:1991;144-148.
35. Granger D.L., Hibbs B.J., Perfect J.R., Durack D.T. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest. 81:1988;1129-1136.
36. James S.L., Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:1989;4208-4212.
37. Beckerman K.P., Rogers H.W., Corbett J.A., Schreiber R.D., McDaniel M.L., Unanue E.R. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immun. 150:1993;888-895.
38. Torre D., Ferrario G., Bonetta G., Perversi L., Speranza F. In vitro and in vivo induction of nitric oxide by murine macrophages stimulated with Bordetella pertussis. FEMS Immunol. Med. Microbiol. 13:1996;95-99.
39. Gearing A.J.H., Bird C., Wadhwa M., Redhead K. The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its components. Clin. Exp. Immunol. 68:1987;275-281.
40. Sakurai S., Kamachi K., Konda T., Miyajima N., Kohase M., Yamamoto S. Nitric oxide induction by pertussis toxin in mouse spleen cells via gamma interferon. Infect. Immun. 64:1996;1309-1313.
41. Unanue E.R. Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2:1984;395-428.
42. Mink C.M., O'Brien C.H., Wassilak S., Deforest A., Meade B.D. Isotype and antigen specificity of pertussis agglutinins following whole cell pertussis vaccination and infection with Bordetella pertussis. Infect. Immun. 62:1994;1118-1120.
43. Medical Research Council Vaccination against whooping cough. Br. Med. J. 4990:1956;454-462.
44. Robinson A., Ashworth L.A.E., Irons L.I. Serotyping Bordetella pertussis strains. Vaccine. 7:1989;491-494.
45. Ashworth L.A.E., Robinson A., Funnell S., Gorring A.R., Irons L.I., Seabrook R.N. Agglutinogens and fimbriae of Bordetella pertussis. Tokai. J. Exp. Clin. Med. 13:1988;203-210.
46. Hibbs J.B., Taintor R. Jr., Vavrin Z. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
47. Nacy C.A., Belosevic M., Meltzer M.S., Hoover D.L. Interferon and nonviral pathogens. Immunol. Ser. 42:1988;167.